Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K002546
    Date Cleared
    2000-10-31

    (75 days)

    Product Code
    Regulation Number
    876.1075
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A protective cover for a mechanical breast biopsy device reusable holster / cable assembly that helps prevent contamination [blood, body fluids, ultrasound gel, etc.] of the holster control buttons, and thus allowing for reprocessing of the holster between patient uses; covers are single use, disposable.

    Device Description

    The CIV-Flex™ Holster Cover device provides a thin, conformal protective covering for the disposable probe / reusable holster and cable assembly components of the Ethicon Endo-Surgery Mammotome® mechanical breast biopsy device. The cover is manufactured as a one-piece sleeve design that is open on both ends with a tapered fit to the holster / probe geometry. The cover material is transparent for visualization of the holster control buttons during use. Cover material is polyurethane film. Material system is free of any latex natural rubber. Covers are packaged sterile in a pouch for single patient / procedure, disposable use. Cover is supplied with latex free Kraton® thermoplastic elastomer bands for use in securing the cover to the holster and cable.

    AI/ML Overview

    The information provided describes a 510(k) premarket notification for the CIV-Flex™ Holster Cover, focusing on demonstrating substantial equivalence to a predicate device, the CIVCO Poly [CIV-Flex™] Ultrasound Transducer Cover (K970513). As this is a submission for a protective cover, the "performance" and "acceptance criteria" are related to its physical properties, biocompatibility, and ability to act as a barrier, rather than diagnostic accuracy metrics typically found in AI/ML device studies.

    Here's an analysis of the provided text, structured to address your specific points where applicable, and noting when information is not present or relevant to this type of device:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided document does not explicitly list "acceptance criteria" in a quantitative, metric-based format as one might expect for a diagnostic device. Instead, it relies on demonstrating substantial equivalence to a predicate device by comparing various parameters and highlighting that the new device meets the same performance and safety standards established for the predicate.

    The "Effectiveness" section offers the closest information to performance, focusing on mechanical integrity and barrier properties.

    Parameter (effectively "Acceptance Criteria")CIV-Flex™ Holster Cover Performance (Reported Performance)
    Intended Use / Indications for UseSame as predicate, except adapted for mechanical breast biopsy reusable holster/cable assembly. Prevents contamination, allowing reprocessing.
    DesignSame as predicate. One-piece, geometry conforming cover.
    MaterialSame as predicate. Polyurethane, thermoplastic. CIVCO trade name CIV-Flex™. Used for over 10 years. (Generally Recognized As Safe - GRAS for this context)
    ManufacturingSame as predicate. Extruded/blown thin film, cut/heat seal, packaged in Class 10,000 cleanroom. Sterile packaging per ANSI/AAMI/ISO 11607. Sterilized by ethylene oxide gas.
    Quality SystemsSame as predicate. FDA/QSR cGMP 21CFR Part 820. ISO 9001 / EN46001 / ISO 13485.
    SterilitySame as predicate. 100% EtO method validated per ANSI/AAMI/ISO 11135. SAL 10-6.
    Device Body Contact CategorySame as predicate. Surface devices, intact skin/mucosal membranes/breached surfaces; limited contact duration (< 24 hours).
    Safety (Biocompatibility)Same as predicate. Non-toxic, non-sensitizing, non-irritating, non-hemolytic, non-pyrogenic. Testing in accordance with ISO 10993-Part 1, FDA Blue Book Memorandum #G95-1, FDA-GLP.
    Effectiveness (Mechanical)Material adequate for intended use during application, removal, and use. Strength and elastic characteristics same as ultrasound cover, allowing use without tearing or pinholing. Same cover thickness of 0.002".
    Effectiveness (Barrier Properties)Provides an effective barrier to the prevention of microbial migration (implies similar performance to predicate which demonstrated this using viral penetration protocol).

    2. Sample Size Used for the Test Set and Data Provenance

    This information is not provided in the document. For this type of device (a protective cover), the "test set" would refer to the samples of the cover material or the covers themselves that underwent various physical, chemical, and biological tests. The document indicates "Mechanical testing for CIV-Flex™ Holster Covers has shown that the material is adequate..." and "Experience and testing has shown that polyurethane covers: ... Provides an effective barrier...", but it does not specify the number of samples or data provenance (e.g., country of origin, retrospective/prospective). This type of detail is often found in the full test reports, which are not included in a 510(k) summary.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    This is not applicable to this type of device submission. Ground truth is typically associated with diagnostic accuracy, where clinical experts (e.g., radiologists, pathologists) determine the true disease state for comparing against an AI algorithm's output. For a physical device like a sterile cover, "ground truth" is established through standardized laboratory tests (e.g., sterility testing, biocompatibility testing, physical strength tests), not expert consensus on medical images or diagnoses.

    4. Adjudication Method for the Test Set

    This is not applicable to this type of device submission for the reasons outlined in point 3. Adjudication methods (like 2+1 or 3+1) are used in clinical studies to resolve disagreements among human readers/experts when establishing ground truth for diagnostic efficacy.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

    This is not applicable to this type of device submission. MRMC studies are used to evaluate the performance of diagnostic systems (often AI-assisted) by comparing multiple readers' interpretations of multiple cases. The CIV-Flex™ Holster Cover is a physical accessory, not a diagnostic tool or an AI-powered system, so such a study would not be relevant.

    6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study Was Done

    This is not applicable to this type of device submission. This question pertains to AI/ML device performance, where "standalone" refers to the algorithm's performance without human interaction. The CIV-Flex™ Holster Cover is a physical medical device.

    7. The Type of Ground Truth Used

    For the CIV-Flex™ Holster Cover, the "ground truth" (or the basis for demonstrating safety and effectiveness) is established through:

    • Standardized Sterility Testing: Validation using ANSI/AAMI/ISO 11135 (Sterilization of health care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process) to achieve a SAL (Sterility Assurance Level) of 10-6.
    • Biocompatibility Testing: In accordance with ISO 10993-Part 1 (Biological evaluation of medical devices), FDA Blue Book Memorandum #G95-1, and FDA-Good Laboratory Practices (GLP), demonstrating non-toxicity, non-sensitization, non-irritation, non-hemolysis, and non-pyrogenicity.
    • Mechanical Testing: Demonstrating adequate strength and elasticity to prevent tearing or pinholing during application, removal, and use.
    • Barrier Property Testing: Performance as an effective barrier to microbial migration, implicitly by being equivalent to the predicate device which had demonstrated this using a viral penetration protocol.

    These are objective, laboratory-based metrics, not subjective expert consensus, pathology, or outcomes data in the clinical sense you might be referring to for diagnostic devices.

    8. The Sample Size for the Training Set

    This is not applicable to this type of device submission. The concept of a "training set" refers to data used to train an AI/ML algorithm. The CIV-Flex™ Holster Cover is a physical accessory and does not involve AI/ML.

    9. How the Ground Truth for the Training Set Was Established

    This is not applicable to this type of device submission for the same reasons as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1